TD Asset Management’s Fate Therapeutics FATE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-25,000
| Closed | -$184K | – | 1383 |
|
2024
Q1 | $184K | Buy |
+25,000
| New | +$184K | ﹤0.01% | 1360 |
|
2023
Q4 | – | Sell |
-141,652
| Closed | -$300K | – | 1414 |
|
2023
Q3 | $300K | Buy |
141,652
+70,826
| +100% | +$150K | ﹤0.01% | 1340 |
|
2023
Q2 | $337K | Hold |
70,826
| – | – | ﹤0.01% | 1323 |
|
2023
Q1 | $404K | Hold |
70,826
| – | – | ﹤0.01% | 1304 |
|
2022
Q4 | $715K | Sell |
70,826
-18,700
| -21% | -$189K | ﹤0.01% | 1208 |
|
2022
Q3 | $2M | Sell |
89,526
-22,714
| -20% | -$507K | ﹤0.01% | 1002 |
|
2022
Q2 | $2.78M | Sell |
112,240
-5,340
| -5% | -$132K | ﹤0.01% | 908 |
|
2022
Q1 | $4.56M | Buy |
117,580
+10,899
| +10% | +$423K | ﹤0.01% | 843 |
|
2021
Q4 | $6.24M | Hold |
106,681
| – | – | 0.01% | 807 |
|
2021
Q3 | $6.32M | Buy |
106,681
+18,871
| +21% | +$1.12M | 0.01% | 764 |
|
2021
Q2 | $7.27M | Sell |
87,810
-800
| -0.9% | -$66.2K | 0.01% | 738 |
|
2021
Q1 | $7.31M | Sell |
88,610
-570
| -0.6% | -$47K | 0.01% | 724 |
|
2020
Q4 | $8.11M | Buy |
89,180
+30,700
| +52% | +$2.79M | 0.01% | 652 |
|
2020
Q3 | $2.34M | Buy |
58,480
+24,100
| +70% | +$963K | ﹤0.01% | 870 |
|
2020
Q2 | $1.18M | Buy |
34,380
+3,271
| +11% | +$112K | ﹤0.01% | 1017 |
|
2020
Q1 | $691K | Sell |
31,109
-3,900
| -11% | -$86.6K | ﹤0.01% | 1100 |
|
2019
Q4 | $685K | Sell |
35,009
-7,100
| -17% | -$139K | ﹤0.01% | 1186 |
|
2019
Q3 | $654K | Buy |
42,109
+200
| +0.5% | +$3.11K | ﹤0.01% | 1137 |
|
2019
Q2 | $851K | Buy |
41,909
+1,700
| +4% | +$34.5K | ﹤0.01% | 1079 |
|
2019
Q1 | $706K | Sell |
40,209
-4,000
| -9% | -$70.2K | ﹤0.01% | 1107 |
|
2018
Q4 | $567K | Buy |
44,209
+3,024
| +7% | +$38.8K | ﹤0.01% | 1195 |
|
2018
Q3 | $671K | Buy |
41,185
+5,785
| +16% | +$94.3K | ﹤0.01% | 1235 |
|
2018
Q2 | $401K | Sell |
35,400
-6,200
| -15% | -$70.2K | ﹤0.01% | 1308 |
|
2018
Q1 | $406K | Buy |
41,600
+22,932
| +123% | +$224K | ﹤0.01% | 1237 |
|
2017
Q4 | $114K | Buy |
+18,668
| New | +$114K | ﹤0.01% | 1322 |
|